Coronavirus Research (2020)

Researchers across the University of Oxford are at the forefront of global efforts to understand the coronavirus (COVID-19) and protect our communities.

The Oxford Vaccine

A new section about the Oxford COVID-19 vaccine team and their race against the global threat to human health that is coronavirus.

Oxford Vaccine screen Oxford Vaccine screen

Oxford Vaccine screen

Latest research and analysis

From vaccine development to mapping, the work involves more than 20 departments from medicine to humanities.

Information for staff and students

Information for anyone at the University with concerns or questions about COVID-19.

Support our research

Find out how to support Oxford’s Pandemic Sciences Institute, which will cover coronavirus research as well as other pandemic threats.

Coronavirus Research (2020) Articles

Oxford vaccine saved most lives in its first year of rollout

Oxford vaccine saved most lives in its first year of rollout

Novel all-in-one vaccine developed to tackle future coronavirus threats

Novel all-in-one vaccine developed to tackle future coronavirus threats

COVID-19 vaccine protects people of all body weights from hospitalisation and death

COVID-19 vaccine protects people of all body weights from hospitalisation and death

Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions

Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions

Com-COV study supports flexible priming intervals in standard/mixed schedules

Com-COV study supports flexible priming intervals in standard/mixed schedules

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

Brain regions related to smell show decline following mild COVID-19

Brain regions related to smell show decline following mild COVID-19

RECOVERY trial shows Baricitinib reduces deaths in patients hospitalised with COVID-19

RECOVERY trial shows Baricitinib reduces deaths in patients hospitalised with COVID-19

COVID-19 Multi-omic Blood Atlas (COMBAT) published

COVID-19 Multi-omic Blood Atlas (COMBAT) published

Meet our researchers

Sarah Gilbert

Sarah Gilbert

Professor Gilbert holds the Saïd Professorship of Vaccinology and has been a part of Oxford’s vaccine community since 1994, working closely with Profe...

Omar El Muhanna

Omar El Muhanna

Omar El Muhanna heads the operations of the Nuffield Department of Medicine's Clinical Biomanufacturing Facility (CBF). He is best known for his succe...

Andrew Pollard

Andrew Pollard

Professor Andrew J Pollard is the chief investigator of the global clinical trials of the Oxford COVID19 vaccine sponsored by the University of Oxford...

Gail Hayward

Gail Hayward

Professor Gail Howard is an Associate Professor in Primary Care with a background in diagnostics and infections. She is also examining how primary car...

Rima Shretta

Rima Shretta

Dr Rima Shretta is an experienced global health expert, with over 20 years of experience in developing effective health system strategies to improve a...

Mark Thompson

Mark Thompson

Mark Thompson is an Associate Professor in Engineering Science and Tutor and Fellow in Engineering Science, Wadham College.

View more researchers

Related websites

Coronavirus: the science explained

Coronavirus: the science explained

UKRI website
Covid-19 Oxford Vaccine Trial

Covid-19 Oxford Vaccine Trial

Website
RECOVERY Trial

RECOVERY Trial

Drug Trial